Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:19 AM
Ignite Modification Date:
2025-12-25 @ 12:19 AM
NCT ID:
NCT00462358
Eligibility Criteria:
Key Inclusion Criteria:
* Histological or cytological evidence of malignancy.
* Advanced solid tumors that have recurred or progressed following standard therapy(ies).
* Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2.
* Adequate hematology counts and serum chemistry values.
* Additional criteria exist.
Key Exclusion Criteria:
* Treatment with an investigational product or device, or anti-neoplastic therapy (with the exclusion of hormone therapy where the therapy will continue at a standard dose throughout the study) within 28 days prior to the first dose of study drug.
* Major surgery within 28 days prior to the first dose of study drug.
* Radiotherapy (RT) within 28 days prior to the first dose of study drug (except if local RT to \<5% of the bone marrow).
* Known positive serology for the human immunodeficiency virus (HIV), hepatitis C, and/or active hepatitis B.
* Additional criteria exist.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00462358
Study Brief:
Protocol Section:
NCT00462358